Focused on novel, nanotechnology-based therapeutics

Oliver Fetzer, Ph.D.
President and Chief Executive Officer

David P. DeMagistris, Ph.D.
Senior Vice President, Pharmaceutical Sciences and Manufacturing

Scott Eliasof, Ph.D.
Senior Director, Research

Alexandra Glucksmann, Ph.D.
Senior Vice President, Research and Business Operations

Karen Roberts
Senior Vice President, Finance and Administration

John Ryan, Ph.D., M.D.
Senior Vice President and Chief Medical Officer

Jean Silveri, J.D.
Senior Vice President, General Counsel

Marc Wolfgang
Senior Director, Pharmaceutical Sciences and Manufacturing

Marc was previously Senior Director of Quality at Momenta Pharmaceuticals, where he was responsible for building the quality organization including the establishment of an in-house cGMP testing laboratory. Prior to joining Momenta, he held various CMC related positions ranging from analytical development, QA/QC, production technology and regulatory affairs at Millennium Pharmaceuticals, Biogen, and Boehringer Ingelheim.

Marc holds degrees in Biology and Chemistry from the Pennsylvania State University and Montclair State University.

Cissy Young, Ph.D.
Director, Strategy and Business Development